Luc Sterkman CEO Caelus Health

Luc Sterkman obtained his medical degree (MD) in 1988 at the Free University in Amsterdam.

Contact options for Luc Sterkman

He has broad experience in the fields of general management, business development and R&D. From 1992 until 2002 he was COO and later CEO of U-Gene Research which was successfully sold to Kendle USA (NASDAQ–KNDL). From 2002 to 2004, Mr Sterkman worked as a Board member of the biotech company OctoPlus and from 2005 to 2010 he was general manager at the pharmaceutical company Disphar International BV (part of the Nordic Group). From 2011 to 2016 he was COO at Newtricious, a company which focuses on innovative nutrition and functional foods. As the CEO at Caelus Health since January 2016, he is responsible for building and directing the company in the next phase of growth and further expanding its pipeline of new microbiota-based products in the field of cardio-metabolic diseases.